You just read:

Tillotts Pharma and Numab Announce Exclusive Development and Licensing Agreement for TNF-Alpha Blockers as Drug Candidates for Inflammatory Bowel Disease

News provided by

Tillotts Pharma AG

09 Jun, 2015, 11:00 BST